ClinicalTrials.Veeva

Menu

Project 3: ACHIEVE- CHD

University Hospitals (UH) logo

University Hospitals (UH)

Status

Enrolling

Conditions

Coronary Heart Disease

Treatments

Other: CINEMA
Behavioral: PAL2

Study type

Interventional

Funder types

Other

Identifiers

NCT05918380
STUDY20220763

Details and patient eligibility

About

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health In Populations Through Early Prevention in the Great Lakes Region) Center (IRB 100221MP2A), the purpose of which is to reduce cardiometabolic health disparities and downstream Black-White lifespan inequality in two cities: Detroit, Michigan, and Cleveland, Ohio. The ACHIEVE GREATER Center will involve three separate but related projects that aim to mitigate health disparities in risk factor control for three chronic conditions, hypertension (HTN, Project 1), heart failure (HF, Project 2) and coronary heart disease (CHD, Project 3), which drive downstream lifespan inequality. All three projects will involve the use of Community Health Workers (CHWs) to deliver an evidence-based practice intervention program called PAL2. All three projects will also utilize the PAL2 Implementation Intervention (PAL2-II), which is a set of structured training and evaluation strategies designed to optimize CHW competence and adherence (i.e., fidelity) to the PAL2 intervention program. The present study is Project 3 of the ACHIEVE GREATER Center.

Enrollment

500 estimated patients

Sex

All

Ages

40 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 40 to 75 years of age

  2. Self-identified as Black or African American

  3. Residence in the Cleveland Metro Area

  4. Must have at least two of the following risk factors identified at a UH health fair screenings, with one risk factor being with SBP, A1c, or LDL:

    1. BMI≥30 mg/dL
    2. History of smoking
    3. Elevated blood pressure defined as SBP>140 or DBP>80 mmHg
    4. HbA1c≥5.7%
    5. LDL≥130
  5. Able to complete a coronary artery calcium score test (CAC)

  6. Willing and able to consent

  7. Willing to have a UH provider and UH care

  8. Currently insured for standard of care procedures

Exclusion criteria

  1. Established documented cardiovascular disease (coronary artery disease, peripheral artery disease, myocardial infarction, stroke).
  2. Systolic blood pressure ≥ 180 mmHg or diastolic blood pressure ≥ 110 mmHg
  3. Lung disease requiring supplemental oxygen therapy
  4. Individuals receiving treatment for cancer related disease
  5. Pregnant or nursing mothers

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

500 participants in 2 patient groups

Low CVD risk
Other group
Description:
PAL2
Treatment:
Behavioral: PAL2
High CVD risk
Other group
Description:
Center for Integrated and Novel Approaches in Vascular-Metabolic Disease (CINEMA)
Treatment:
Other: CINEMA

Trial contacts and locations

1

Loading...

Central trial contact

Heidi Osborne; Sanjay Rajagopalan, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems